IgA nephropathy trials in Switzerland

1 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• No phaseNot yet taking people in Switzerland
  Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

  Where

  Zurich

  Age

  18 years and over

  People

  50

  Run by

  Waid City Hospital, Zurich

  See details and how to joinNCT07555301